Ignite Creation Date:
2024-05-06 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03661320
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-30
First Post:
2018-09-05
Brief Title:
A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205 Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Organization Data
Organization:
Bristol-Myers Squibb
Class:
INDUSTRY
Study ID:
CA017-078
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bristol-Myers Squibb
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Ono Pharmaceutical Co Ltd | INDUSTRY |